Patent · US Active

Nucleoside phosphoramidate prodrugs

US7964580B2 · kind B2 · utility

156Cited by

115References

14Claims

0Family size

Assignee

Pharmasset, Inc. · US

Inventors

Michael Joseph Sofia · Carmel, US
Jinfa Du · New Hope, US
Peiyuan Wang · San Mateo, US

Key dates

Filing date	Mar 21, 2008
Grant date	Jun 21, 2011
Priority date	—
Expiry date	Mar 26, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure:Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.